ArticleJTCVS open2025
Outcomes after cardiac surgery in patients with epilepsy: A nationwide analysis.
Article in JTCVS open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To assess outcomes after cardiac surgery in patients with epilepsy. Methods: We queried the 2016-2019 Nationwide Readmissions Database for adult patients undergoing coronary artery bypass grafting, valve and aortic surgeries, or combination procedures. We compared mortality at index admission, complications, and 90-day readmissions between groups of patients with and without epilepsy before and after propensity-score matching. We used logistic regression analysis to evaluate the risk of adverse postoperative outcomes in the epilepsy group compared with their counterparts without epilepsy. Results: There were 1,104,303 patients identified who underwent cardiac surgery; of those, 15,492 (1.4%) had epilepsy. Patients with epilepsy more often had additional comorbidities, including congestive heart failure, chronic lung disease, and renal failure. Even after propensity-score matching, mortality at index admission (5.2% vs 3.6%), overall complications (44.2% vs 31.4%), and 90-day readmissions (27.3% vs 21.3%) were greater among patients with epilepsy than those without ( Conclusions: Further studies are necessary to identify strategies to improve outcomes after cardiac surgery in patients with epilepsy, as they have greater associated risks of postoperative mortality, complications, and readmission.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.